embolic stroke in acute setting - Nursing Case Study
Pathophysiology
• Primary mechanism: An embolic stroke occurs when a blood clot or debris forms elsewhere in the body, often in the heart, and travels through the bloodstream until it lodges in a cerebral artery, obstructing blood flow and causing ischemia in brain tissue.
• Secondary mechanism: The lack of blood flow leads to a rapid depletion of oxygen and glucose in the affected brain area, resulting in neuronal cell death and loss of neurological function in the specific region supplied by the blocked artery.
• Key complication: If not promptly treated, the ischemia can lead to irreversible brain damage, increased intracranial pressure, and risk of hemorrhagic transformation, where the infarcted area bleeds, worsening the patient's condition.
Patient Profile
Demographics:
65 years old, female, retired school teacher
History:
• Hypertension, atrial fibrillation, type 2 diabetes
• Warfarin, metformin, lisinopril, atorvastatin
• Allergic to penicillin
Current Presentation:
• Chief complaint: Sudden onset of weakness on the right side of the body and difficulty speaking
• Key symptoms: Right-sided hemiparesis, slurred speech, facial droop on the right side, slight confusion
• Vital signs: Blood pressure 175/95 mmHg, heart rate 110 bpm (irregular), respiratory rate 22 breaths per minute, temperature 98.6°F, oxygen saturation 92% on room air
Section 1
Initial Assessment Findings:
Upon further assessment in the emergency department, the patient's neurological evaluation revealed a National Institutes of Health Stroke Scale (NIHSS) score of 14, indicating a moderate to severe stroke. The right-sided hemiparesis was more pronounced in the upper extremity, with significant weakness and decreased grip strength. Her speech was characterized by expressive aphasia, and comprehension was moderately impaired, suggesting involvement of the left middle cerebral artery territory. Pupillary response was normal, but there was evidence of right homonymous hemianopia, indicating a possible visual field deficit. Cardiac auscultation confirmed an irregularly irregular heart rhythm consistent with atrial fibrillation, which aligns with the suspected embolic source of the stroke.
Laboratory tests were promptly conducted, revealing the following critical values: an INR of 1.8, which is subtherapeutic for her condition of atrial fibrillation, suggesting inadequate anticoagulation. Blood glucose was elevated at 210 mg/dL, indicative of poor glycemic control, which may exacerbate cerebral ischemia. The CT scan of the head was unremarkable for hemorrhage, supporting the diagnosis of an ischemic stroke. However, a CT angiogram showed occlusion in the left middle cerebral artery, confirming the site of embolic obstruction.
These findings highlight the urgent need for intervention. The decision to proceed with thrombolytic therapy or endovascular clot retrieval was considered, balancing the risks given her subtherapeutic INR and potential for hemorrhagic transformation. The clinical team also discussed optimizing her anticoagulation strategy post-acute management, considering her atrial fibrillation and history of suboptimal warfarin control, to prevent further embolic events. The patient's family was involved in discussions about the potential benefits and risks of interventions, emphasizing the importance of timely decision-making to mitigate neurological deficits and improve functional outcomes.
Section 2
As the clinical team proceeded with the decision to administer thrombolytic therapy, they closely monitored the patient for any changes in her neurological status and potential complications. Within an hour of receiving tissue plasminogen activator (tPA), the patient exhibited subtle improvements in her expressive aphasia, with slightly clearer speech and improved comprehension. However, the right-sided hemiparesis persisted, and her NIHSS score showed only a slight reduction to 12, indicating the need for continued vigilance and supportive care.
Approximately three hours post-thrombolysis, the patient developed a new onset of headache and worsening confusion, prompting immediate reassessment. A repeat CT scan of the head was performed to evaluate for possible hemorrhagic transformation, given the risk associated with thrombolytic therapy. The scan revealed a small hemorrhagic conversion at the site of the initial ischemic stroke, necessitating a careful reevaluation of her treatment plan. The patient's blood pressure was noted to be slightly elevated at 160/95 mmHg, potentially contributing to the risk of hemorrhage, and her blood glucose remained elevated at 198 mg/dL, requiring further management to optimize cerebral metabolism.
In response to these new complications, the clinical team initiated measures to carefully lower her blood pressure with intravenous antihypertensives and adjusted her glucose management to achieve better control. Neurology and hematology specialists were consulted to discuss the implications of the hemorrhagic transformation and to refine her anticoagulation strategy moving forward. The patient's family was updated on her condition, and the importance of monitoring for further neurological changes was emphasized, as the team worked collaboratively to stabilize her status and plan for rehabilitation to maximize her recovery potential.
Section 3
The clinical team continued to closely monitor the patient's condition following the new onset of headache and confusion. Over the next few hours, her neurological status remained stable with no further worsening of symptoms, and her headache was managed effectively with acetaminophen. However, a subsequent neurological examination revealed a slight increase in the right-sided hemiparesis, raising concerns about potential further complications. Vital signs showed a stabilized blood pressure at 145/90 mmHg after the administration of intravenous antihypertensives, and her blood glucose levels were brought down to 150 mg/dL with an adjusted insulin regimen.
Laboratory results indicated a modest drop in hemoglobin levels to 11.2 g/dL, suggesting a mild degree of blood loss secondary to the hemorrhagic transformation. The neurology team decided to hold off on further anticoagulation therapy until the patient's condition was more stable, focusing instead on optimizing supportive care. A repeat CT scan was scheduled for the following morning to assess the evolution of the hemorrhagic transformation and guide further management decisions. In the meantime, the patient was placed on strict neurological checks every hour to monitor for any sudden changes that might indicate an enlargement of the hemorrhage or additional complications.
As the multidisciplinary team convened to discuss the patient's progress, the focus shifted towards planning a comprehensive rehabilitation strategy. The aim was to address her persistent hemiparesis and aphasia while ensuring that her medical stability was prioritized. The emphasis on early mobilization, speech therapy, and occupational therapy was highlighted, with the recognition that her recovery would require a coordinated effort across various healthcare disciplines. The patient's family remained engaged and informed, understanding the critical balance between managing her acute medical needs and initiating steps towards her long-term recovery.
Section 4
As the clinical team continued to monitor the patient closely, a new complication emerged early in the morning. During a routine neurological check, the patient was found to have a sudden increase in confusion and a noticeable decline in her ability to follow simple commands. Her speech became more garbled, and she struggled to articulate words that she previously managed with some effort. Vital signs showed a slight increase in blood pressure to 152/94 mmHg, and her heart rate rose to 110 beats per minute. These changes prompted an urgent reassessment of her condition, given the potential for further neurological deterioration.
The repeat CT scan, performed promptly, revealed a slight expansion of the previous hemorrhagic transformation with surrounding edema. The radiologist noted a moderate midline shift, which explained the acute changes in her neurological status. Blood tests indicated a further drop in hemoglobin to 10.8 g/dL, suggesting ongoing minor bleeding. The multidisciplinary team faced the challenge of balancing the need to manage the evolving hemorrhagic component while avoiding further compromise of her recovery from the embolic stroke.
In response to these findings, the team adjusted her management plan, prioritizing measures to reduce intracranial pressure. Mannitol was administered to address cerebral edema, and her head was elevated to improve venous drainage. The decision to withhold anticoagulation was reinforced, focusing instead on meticulous blood pressure control and close hemodynamic monitoring. This development necessitated a temporary pause in her rehabilitation efforts, underscoring the need for vigilant observation and swift intervention to stabilize her condition before resuming her recovery trajectory. The patient's family was updated on the situation, understanding that the path to recovery may involve setbacks that require adaptation and patience.
Section 5
As the day continued, the patient exhibited a mixed response to the interventions. Her vital signs stabilized somewhat, with her blood pressure lowering to 140/88 mmHg and heart rate settling at 102 beats per minute, suggesting that the measures to manage intracranial pressure were having a positive effect. However, despite these physiological improvements, her neurological status remained concerning. She continued to experience significant confusion and demonstrated no improvement in her speech capabilities, maintaining a garbled and incoherent pattern. The clinical team noted that her left-sided weakness persisted, with no voluntary movement in her left arm and only minimal movement in her left leg, indicating that the hemorrhagic transformation and cerebral edema were still exerting considerable pressure on her brain's functional areas.
In light of the mixed response to treatment, the team decided to conduct a more comprehensive evaluation of her electrolyte balance and renal function, given the administration of mannitol. The subsequent laboratory results revealed a sodium level of 147 mmol/L, at the upper limit of normal, and a potassium level of 3.4 mmol/L, slightly below the normal range. Her blood urea nitrogen and creatinine levels were within normal limits, suggesting that renal function was not significantly compromised at this stage. These findings prompted the team to adjust her fluid management strategy, emphasizing careful monitoring of electrolyte balance to prevent potential complications like osmotic demyelination syndrome.
With the immediate focus on stabilizing her condition, the clinical team discussed the possibility of introducing a neuroprotective agent to help mitigate further neurological damage while continuing to manage intracranial pressure and avoid additional bleeding. They also considered the potential need for surgical intervention should her condition fail to improve or deteriorate further. The patient's family was briefed on these developments, understanding that while the current situation was challenging, the team's careful and considered approach aimed to maximize her chances of recovery, even if the path forward remained uncertain.